Abstract 10944: Cardiac Magnetic Resonance Derived Left Atrioventricular Coupling Index and Major Adverse Cardiac Events in Patients Following Myocardial Infarction

Torben LangeSoeren J BackhausAlexander SchulzRuben EvertzJohannes KowallickBoris BigalkeGerd HasenfussHolger ThieleThomas StiermaierIngo EitelAndreas SchusterUnivMedCntr Goettingen,GoettingenUniv Hosp Goettingen,GoettingenGoettingenUniv Med Cntr Goettinge,GoettingenUniv Med Cntr Göttingen,GoettingenCharite,Berlin,GermanyUniv Medicine Göttingen,GottingenLeipzigLübeckUniv Heart Cntr Lübeck,LübeckUniv Medicine Göttingen,Goettingen,Germany
DOI: https://doi.org/10.1161/circ.146.suppl_1.10944
IF: 37.8
2022-11-01
Circulation
Abstract:Circulation, Volume 146, Issue Suppl_1, Page A10944-A10944, November 8, 2022. Introduction:Recently a novel left atrioventricular coupling index (LACI) has been introduced providing prognostic value to predict cardiovascular events beyond common risk factors in patients without cardiovascular disease. Since data on cardiovascular magnetic resonance (CMR)-derived LACI in patients following acute myocardial infarction (AMI) are scare we aimed to assess and validate the diagnostic and prognostic implications of LACI in a large AMI patient cohort.Methods:1044 patients following AMI were included. After primary percutaneous coronary intervention CMR imaging and subsequent functional analyses were performed in median 3 days after AMI. LACI was defined by the ratio of the left atrial end-diastolic volume divided by the left ventricular end-diastolic volume. Major adverse cardiac events (MACE) including death, reinfarction or congestive heart failure within 12 months after the index event were defined as primary clinical endpoint.Results:LACI was significantly higher in patients with MACE compared to those without MACE (p < 0.001). Youden Index identified an optimal LACI cut-off of 34.7% to classify patients at high-risk (p < 0.001 on log-rank testing). Greater LACI was independently associated with MACE on univariate regression modeling (HR 8.1, 95% CI 3.4% - 14.9 %, p < 0.001) and maintained independence after adjusting for baseline confounders and left ventricular ejection fraction (LVEF) on multivariate regression analyses (HR 3.1 95% CI 1.0 - 9., p = 0.049). Furthermore, LACI assessment enabled further risk stratification in high-risk patients according to traditionally utilized reduced LVEF ≤ 35 % (p < 0.001 on log-rank testing).Conclusions:Atrial-ventricular interaction using CMR-derived LACI is a superior measure of outcome beyond sole LA or LV volume analyses and EF especially in high-risk patients following AMI.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?